David Carmel

David A. Carmel is a prominent executive in the biotechnology and healthcare sectors who currently serves as the Chief Growth and Innovation Officer at the Foundation for the National Institutes of Health (FNIH).13 He joined the FNIH in September 2022 as the organization's first Chief Growth and Innovation Officer, where he is a key member of the executive leadership team.12

Career Highlights

Biotech and Healthcare Experience:: Carmel has an extensive background in the biotechnology industry. Prior to joining FNIH, he held several notable positions:

• Senior Vice President of Public Affairs and Communications at eGenesis, where he led a $125 million Series C financing round.3
• Vice President at Atara Biotherapeutics, managing collaborations with major research institutions.3
• Principal at Carmel Asset Management, where he led life science investments.3
• Vice President of Business Development at StemCyte, Inc.3

Government and Advisory Roles::

• Served as a White House Fellow from 2002 to 2003.1
• Appointed by Governor Andrew Cuomo to the New York Life Science Advisory Board.13

Education and Achievements

Carmel's educational background includes:

• Bachelor's degree, magna cum laude, from Harvard College.1
• MBA with a certificate in healthcare from Stanford Graduate School of Business.13

He is also recognized as a Henry Crown Fellow of the Aspen Institute.1

Personal Impact

An unexpected personal event significantly influenced Carmel's career path. In 1999, he sustained a spinal cord injury in a diving accident.4 This experience led him to focus on healthcare and biotechnology, driving his passion for bringing new therapies to patients.4

Current Role and Initiatives

At FNIH, Carmel leads the communications and events divisions, aiming to expand the foundation's scale and impact.1 His role involves bridging his expertise in biotechnology, business development, and public affairs to advance the mission of the FNIH in supporting biomedical research and innovation.